glycogen synthase kinase

Top PDF glycogen synthase kinase:

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging

Glycogen synthase kinase-3 (GSK-3) is expressed in all tissues and is a member of the protein kinase family, a group of enzymes that catalyze the transfer of a phosphate group from adenosine triphosphate (ATP) to target substrates. GSK-3 is a ser- ine/threonine kinase, and thus transfers a phosphate group to either the serine or threonine residues of its substrates.[1] The mechanism of phosphorylation regulates various complex biological processes, in- cluding metabolism (glucose regulation),[2-6] cell signaling,[7-9] cellular transport,[10-12] apoptosis,[13-15] proliferation, and intracellular communication.[16] Additional roles for GSK-3 in biological processes are likely to be identified in the future.[16] Phosphorylation is a key regulatory step that initiates, enhances, or inhibits the function of a target substrate. Given the breadth of processes asso- ciated with GSK-3, it is not surprising that GSK-3 has emerged as an important target for drug development and medical imaging in various diseases.
Show more

23 Read more

Glycogen synthase kinase 3: cryoprotection and glycogen metabolism in the freeze tolerant wood frog

Glycogen synthase kinase 3: cryoprotection and glycogen metabolism in the freeze tolerant wood frog

both GP and GS, inactivating the former and activating the latter (Dent et al., 1990; Roach, 1990). Insulin signalling also activates GS via another mechanism: the phosphorylation and inactivation of glycogen synthase kinase-3 (GSK-3), a protein kinase that, when active, phosphorylates and inactivates GS (Sutherland et al., 1993; Summers et al., 1999). When GSK-3 is phosphorylated and inactivated, GS can be dephosphorylated and activated, allowing glycogenesis to occur. In addition to its role in glycogen metabolism, GSK-3 has been shown to be a master kinase and is recognized to have roles in: (i) the Wnt signalling pathway, known to regulate several physiological processes as well as development, embryogenesis and cancer (Ding and Dale, 2002); (ii) protein synthesis (Welsh and Proud, 1993); (iii) the response to DNA damage (Watcharasit et al., 2002); (iv) the immune response (Beals et al., 1997); and (v) regulation of Tau protein in neurodegenerative disease (Medina et al., 2011), among others.
Show more

9 Read more

Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia

Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia

Glycogen synthase kinase 3 (GSK-3) is a  ser- ine/tyrosine kinase identified in skeletal muscle. To date, two isoforms of GSK-3 have been reported: the first, 51 kDa (GSK-3α), and the second, 47 kDa (GSK-3β). The activity of GSK-3 can be inhibited by Akt-mediated phosphorylation at Ser21 in GSK-3α and at Ser9 in GSK-3β. The aberrant expression of GSK-3β has been demonstrated in metabolic dis- orders and in hematopoietic stem cell differenti- ation and proliferation  [2]. Several studies have been performed by means of cell culture and im- munohistochemistry and have shown that GSK-3β is found significantly accumulated in the nuclei of cells in patients with ALL. Furthermore, selective inhibition of GSK-3β induces cell death mediated by downregulation of the transcriptional activity of hematopoietic nuclear factor kappa-light-chain-en- hancer of activated B cells (NFKB). Thus, GSK-3β inhibitors significantly decreased NFKB expression, generating gene suppression and stimulating apop- tosis in vitro, which suggested its being a novel, in- teresting target in ALL treatment   [3]. Even more
Show more

9 Read more

Regulation of Flagellar Assembly by Glycogen Synthase Kinase 3 in Chlamydomonas reinhardtii

Regulation of Flagellar Assembly by Glycogen Synthase Kinase 3 in Chlamydomonas reinhardtii

Chlamydomonas reinhardtii controls flagellar assembly such that flagella are of an equal and predetermined length. Previous studies demonstrated that lithium, an inhibitor of glycogen synthase kinase 3 (GSK3), induced flagellar elongation, suggesting that a lithium-sensitive signal transduction pathway regulated flagel- lar length (S. Nakamura, H. Takino, and M. K. Kojima, Cell Struct. Funct. 12:369-374, 1987). Here, we demonstrate that lithium treatment depletes the pool of flagellar proteins from the cell body and that the heterotrimeric kinesin Fla10p accumulates in flagella. We identify GSK3 in Chlamydomonas and demonstrate that its kinase activity is inhibited by lithium in vitro. The tyrosine-phosphorylated, active form of GSK3 was enriched in flagella and GSK3 associated with the axoneme in a phosphorylation-dependent manner. The level of active GSK3 correlated with flagellar length; early during flagellar regeneration, active GSK3 increased over basal levels. This increase in active GSK3 was rapidly lost within 30 min of regeneration as the level of active GSK3 decreased relative to the predeflagellation level. Taken together, these results suggest a possible role for GSK3 in regulating the assembly and length of flagella.
Show more

13 Read more

Activation of GABAB receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signaling

Activation of GABAB receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signaling

Accumulated evidence has suggested that potentiation of cortical GABAergic inhibitory neurotransmission may be a key mechanism in the treatment of schizophrenia. However, the downstream molecular mechanisms related to GABA potentiation remain unexplored. Recent studies have suggested that dopamine D2 receptor antagonists, which are used in the clinical treatment of schizophrenia, modulate protein kinase B (Akt)/glycogen synthase kinase (GSK)-3 signaling. Here we report that activation of GABA B receptors significantly inhibits Akt/GSK-3 signaling in a

10 Read more

The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil

The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil

Cultured hippocampal neurons exposed to NMDA show a rapid and nearly complete dephosphorylation of phospho-Ser9-GSK-3β, indicating that NMDA receptor signaling activated glycogen synthase kinase-3β (GSK-3β) [7, 8]. In vivo blockage of NMDA receptors by administration of the antagonist increased mouse brain serine-phosphorylation [9, 8]. GSK-3β is a serine/threonine kinase that regulates numerous signaling pathways involved in cell cycle control and cell proliferation, differentiation and apoptosis [10, 11]. It is known to play a proapoptotic role in neurons and other tissues [12-14].
Show more

13 Read more

Phosphoproteomic Characterization Of Glycogen Synthase Kinase-3

Phosphoproteomic Characterization Of Glycogen Synthase Kinase-3

Glycogen Synthase Kinase-3 (GSK-3) is a constitutively active, ubiquitously expressed kinase that acts as a critical regulator of many signaling pathways. These pathways, when dysregulated, have been implicated in many human diseases, including bipolar disorder (BD), cancer, and diabetes. Over 100 putative GSK-3 substrates have been reported, based on direct kinase assays or genetic and pharmacological manipulation of GSK-3, in diverse cell types. Many more have been predicted based upon on the prevalence of the GSK-3 consensus sequence. As a result, there remains an unclear picture of the complete GSK-3 phosphoproteome. We have therefore used a large-scale mass spectrometry approach to analyze global changes in phosphorylation and describe the repertoire of GSK-3 substrates in a single cell type. For our studies, we used stable isotope labeling of amino acids in culture (SILAC) to compare the phosphoproteome of wild-type mouse embryonic stem cells (ESCs) to ESCs completely lacking Gsk3a and Gsk3b expression (Gsk3 DKO). We used titanium oxide chromatography to enrich for phosphorylated peptides. From our analysis, we selected 65 phosphoproteins that exhibited significantly reduced phosphorylation in Gsk3 DKO ESCs as high-confidence candidate
Show more

124 Read more

BIOLOGICAL EVALUATION OF GLYCOGEN   SYNTHASE KINASE-3 Β INHIBITORS AS ANTIDIABETIC AGENT

BIOLOGICAL EVALUATION OF GLYCOGEN SYNTHASE KINASE-3 Β INHIBITORS AS ANTIDIABETIC AGENT

Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. GSK3 was discovered over 20 years ago as one of several protein kinases that phosphorylated and inactivated glycogen synthase, the final enzyme in glycogen biosynthesis. Three isoforms of GSK-3 have been identified in mammalian cells, GSK-3α, GSK- 3β, and GSK 3β2 (a splicing variant of GSK-3β). The β isoforms show a substantial deviation in protein sequence, mostly outside the kinase core (308 residues), but the core has 97% sequence similarity and overall 91% identity. Glycogen synthase kinase (GSK-3β) is a serine/threonine kinase that phosphorylates glycogen synthase and inhibits its activity. Thus, inhibition of GSK-3β is expected to activate glycogen synthase and promote glucose uptake into muscle in that way it decreases the blood glucose level. 1
Show more

12 Read more

Glycogen synthase kinase-3 is required for axon growth and development

Glycogen synthase kinase-3 is required for axon growth and development

Glycogen synthase kinase-3 (GSK-3) is a widely expressed and highly conserved serine/threonine kinase. It was originally identified as key regulatory kinase that phosphorylates and inhibits glycogen synthase downstream of insulin signaling (Embi et al., 1980). However, it has since been shown to play far broader roles in many cellular processes (Cohen and Frame, 2001; Doble and Woodgett, 2003). There are two mammalian GSK-3 isoforms encoded by distinct genes: GSK-3α and GSK-3β. The two proteins share 97% sequence similarity within their kinase catalytic domains, but differ significantly from one another outside this region (Woodgett, 1990).
Show more

60 Read more

Integrin Linked Kinase Is a Functional Mn2+ Dependent Protein Kinase that Regulates Glycogen Synthase Kinase 3β (GSK 3β) Phosphorylation

Integrin Linked Kinase Is a Functional Mn2+ Dependent Protein Kinase that Regulates Glycogen Synthase Kinase 3β (GSK 3β) Phosphorylation

invariant APE motif. Mutation of K220 to alanine or methionine has shown that K220 is essential for ILK function in vitro and in vivo. Specifically, K220 of ILK has been shown to be essential for kidney development and function [45], in enhancing adhesion and focal adhesions during bacterial colonization of epithelial cells [52], and in cardiac function [13,43]. Although the effect of the ‘‘knock-in’’ K220M mutation of ILK on renal development and function was attributed to an adaptor role of ILK in impaired parvin interaction [45], it is equally likely that it is due to impaired kinase activity. Indeed, the crystal structure of the ILK kinase domain in complex with a-parvin indicates that the K220 ATP- binding motif is well separated from the a-parvin-contacting residues, M402 and K403 in the G helix, and parvin does not have a direct effect on ATP binding [47], making it unlikely that the major developmental effect of mutating K220 is solely through a- parvin binding.
Show more

10 Read more

Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer

Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer

GSK-3 β inhibitors may inhibit cell proliferation through modulating cyclin-dependent kinases (CDKs). CDKs bind to cyclins, forming complexes that have protein kinase activ- ity, promoting cell cycle phase transition, initiating DNA synthesis, and regulating cellular transcription and other functions; for example, CDK1 and cyclin B1 accelerate cell division and cell cycle progression via forward regulation. 22,23

8 Read more

SYNTHESIS & PREDICTING THE POSSIBILITY OF 2, 5 DISUBSTITUTED 1, 3, 4 OXADIAZOLE DERIVATIVES AS GSK  3β INHIBITORS

SYNTHESIS & PREDICTING THE POSSIBILITY OF 2, 5 DISUBSTITUTED 1, 3, 4 OXADIAZOLE DERIVATIVES AS GSK 3β INHIBITORS

3F7Z Protein Preparation: Docking calculations were carried out on 2PRG protein model. Essential hydrogen atoms, Kollman united atom type charges, and solvation parameters were added with the aid of AutoDock tools 25 (Morris, Goodsell et al., 1998). Affinity (grid) maps of 20×20×20 Å grid points and 0.375 Å spacing were generated using the Autogrid program. AutoDock parameter set- and distance- dependent dielectric functions were used in the calculation of the van der Waals and the electrostatic terms, respectively. Figure 2 shows the x-ray co-crystal structure of the Glycogen synthase kinase-3beta protein.
Show more

9 Read more

Mechanism and evolution of cytosolic Hedgehog signal transduction

Mechanism and evolution of cytosolic Hedgehog signal transduction

Fig. 4. Hedgehog signaling complex function in Drosophila and mouse. Modes of action of the Hh signaling complex. Matching colors denote homologs. (A)  In Drosophila, Cos2 associates with microtubules and scaffolds PKA, CKI and GSK3. This leads to efficient phosphorylation of Ci-155 and limited proteolysis to generate Ci-75. (B)  Cos2 binds to the C-tail of Smo when Smo is in its active conformation, leading to the dissociation of PKA, CKI and GSK3. Fu is phosphorylated and in turn phosphorylates Cos2, which might promote the dissociation of Ci-155, leading to activation of Hh target genes. Removal of components of the Hh signaling complex has variable effects on Ci-155 and Ci-75 levels, and the relationship of these protein levels to the activation or repression of Hh target genes is not completely understood. (C)  In the mouse, Gli2 and Gli3 are present in small amounts on the primary cilium in the absence of Hh ligand, and the cilium is required for generation of Gli repressors. Kif7 is located at the base of the cilium. (D)  Kif7 binds Gli proteins and regulates their translocation to the primary cilium after stimulation of a cell with Hh ligand. Cilia promote activation of Gli2 and Gli3 through unknown mechanisms. Kif7 might also bind Smo, and Smo is required for Kif7 to move up the cilia. The precise makeup of the vertebrate complex in the absence and presence of Hh remains to be determined, although genetic evidence demonstrates that Fu is not an essential part of it. Ci, Cubitus interruptus; CKI, casein kinase I; Cos2, Costal2; FL, full-length; Fu, Fused; GSK3, glycogen synthase kinase 3; Hh, Hedgehog; Kif7, kinesin family member 7; P, phosphate group; PKA, protein kinase A; R, repressor; Smo, Smoothened; Su(fu), Suppressor of fused.
Show more

16 Read more

Novel Roles for the Tumor Suppressor APC Through Regulation of GSK-3

Novel Roles for the Tumor Suppressor APC Through Regulation of GSK-3

Huang, J., Zhang, Y., Bersenev, A., O’Brien, W.T., Tong, W., Emerson, S.G., and Klein, P.S. (2009b). Pivotal role for glycogen synthase kinase–3 in hematopoietic stem cell homeostasis in mice. Journal of Clinical Investigation 119, in press. Huang, S.M., Mishina, Y.M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G.A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009c). Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461, 614-620. Hurlstone, A.F., Haramis, A.P., Wienholds, E., Begthel, H., Korving, J., Van Eeden, F., Cuppen, E., Zivkovic, D., Plasterk, R.H., and Clevers, H. (2003). The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 425, 633- 637.
Show more

157 Read more

Amniotic fluid exerts a neurotrophic influence on fetal neurodevelopment via the ERK/GSK-3 pathway

Amniotic fluid exerts a neurotrophic influence on fetal neurodevelopment via the ERK/GSK-3 pathway

Results: We used AF that was extracted from embryos at 16 days in pregnant SD rat and exposed the AF to the neural cells derived from the embryos of same rat. We found that the treatment of AF to cortical neurons increased the phosphorylation in ERK1/2 that is necessary for fetal neurodevelopment, which was inhibited by the treatment of MEK inhibitors. Moreover, we found the subsequent inhibition of glycogen synthase kinase‑3 (GSK‑3), which is an important determinant of cell fate in neural cells. Indeed, AF increased the neural clustering of cortical neurons, which revealed that the clustered cells were proliferating neural progenitor cells. Accordingly, we confirmed the ability of AF to increase the neural progenitor cells through neurosphere formation. Furthermore, we showed that the ERK/GSK‑3 pathway was involved in AF‑mediated neurosphere enlargement.
Show more

10 Read more

Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease

Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease

The characterization of full-length Tau has shown that the Tau protein can undergo many transitional conforma- tions, and each of the conformations may represent a po- tentially toxic object. Accumulation of the misfolded Tau intermediates in the human brain causes tauopathies, the most common form of AD [8]. The PI3K/ AKT /GSK-3β pathway appears to be crucial for AD because it promotes protein hyper-phosphorylation in Tau. In particular, glycogen synthase kinase-3β (GSK-3β) plays a key role in the neuronal response to stress by phosphorylating and compromising the transcriptional activity of the cAMP re- sponse element binding, which regulates the transcription of the brain-derived neurotrophic factor (BDNF) and other neuropeptides that are important in the regulation of long-term memory and in the maintenance of synaptic plasticity, thereby contributing to the pathology of neuronal degeneration [9,10]. Furthermore, GSK-3β is probably the most documented kinase implicated in the abnormal hyper-phosphorylation of Tau protein.
Show more

7 Read more

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

One postulated mechanism for the anti-migratory effects of LiCl and BIO is through GSK-3 inhibition. Glycogen synthase kinase-3 is thought to be involved in the control of cell migration, through its role in regulating cellular structure alongside microtubule and focal adhesion dynamics (Grimes and Jope, 2001; Sun et al, 2009). In adult HGG, the effect of LiCl and BIO on migration has previously been investigated and their anti-migratory activity has been attributed to their ability to inhibit GSK-3 and stabilise b-catenin via the canonical Wnt signalling pathway (Luo, 2009). In adult glioma models, LiCl has been shown to increase b-catenin reporter activity and b-catenin knockdown has been demonstrated to rescue the anti-migratory effects of BIO (Nowicki et al, 2008; Williams et al, 2011). In our study, we examined b-catenin localisation by IF post treatment of pHGG cells with LiCl and BIO, and observed a marked internalisation of b-catenin to the cytoplasm and nucleus following treatment. This observation has also been noted in adult glioma following LiCl and BIO treatment (Williams, 2011) and provides evidence to support the effectiveness of LiCl and BIO as an inhibitor of GSK-3. Furthermore, western blot analysis of our pHGG lines confirmed that LiCl increased Ser9 phosphorylated GSK-3b (inactivated form) and BIO decreased the activating tyrosine of GSK-3ab.
Show more

11 Read more

The traditional Chinese formulae Ling gui zhu gan decoction alleviated non alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules

The traditional Chinese formulae Ling gui zhu gan decoction alleviated non alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules

NAFLD can affect glycogen metabolism [8], which is the primary storage form of excess energy. Protein phosphatase 1 regulatory subunit 3C (PPP1R3C) is an enzyme that binds to protein phosphatase-1 (PP1) as a regulator which can mediate glycogen metabolism [9]. PPP1R3C encoded protein is called protein targeting to glycogen (PTG) [10]. PTG overexpression can increase glycogen storage [11]. PTG knocked-down could sup- press the cellular glycogen level in mice, and heterozy- gous deletion of PTG in mice also showed glucose and insulin resistance [12, 13]. Glycogen synthase kinase 3β (GSK3β), glycogen synthase (GS) and glycogen phos- phorylase liver type (PYGL) are the down-steam targets of PTG [14, 15]. PTG enhances the de-phosphorylation of GS and causes the activation of glycogen synthesis [16–18]. GSK3β also takes part in regulating the phos- phorylation of GS. PTG is reported to inhibit PYGL ex- pression and phosphorylase (GPa) de-phosphorylation [16, 17], the phosphorylated form of GPa is catalytically active and catalyzes glycogenolysis in liver.
Show more

11 Read more

Inhibitory interactions of Coenzyme Q10 with selected key enzymes of glucose metabolism: An in silico approach

Inhibitory interactions of Coenzyme Q10 with selected key enzymes of glucose metabolism: An in silico approach

CoQ10 is reported to prevent and treat heart ailments, atherosclerosis, heart failure and coronary artery disease[18]. It also helps in decreasing diabetic complications by increasing the response to oxidative stress[19], decreasing serum glutaredoxin 1(Grx1) and total antioxidant capacity[20]. Human glycogen synthase kinase 3-β helps in pathogenesis of oxidative stress, mitochondrial dysfunction and disorders related to central nervous system (CNS). It also plays an important role in alternating cellular function[20,21]. Alpha amylase helps in carbohydrate metabolism[22].
Show more

6 Read more

Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathway

Rhodiola crenulata extract regulates hepatic glycogen and lipid metabolism via activation of the AMPK pathway

glycogen and lipid metabolism. Biosynthesis of glycogen and lipids is the primary means by which the body stores excess nutrients and is strictly controlled by a complex network of hormones and metabolic signals. Under nor- mal conditions, glycogen is the primary storage form of excess energy. Glycogen production is regulated primarily via enzymes critically involved in glycogen metabolism, including glycogen synthase kinase 3β (GSK3β) and glyco- gen synthase (GS) [8]. However, insulin resistance shifts the major form of energy storage from glycogen to triglyc- erides (TG) in the liver [9], consistent with reduced GS ac- tivity in patients with type II diabetes [10]. These shifts in energy storage mechanisms increase lipogenesis, enhance cholesterol synthesis, and decrease fatty acid β-oxidation; eventually, such effects may lead to lipotoxicity-induced pancreatic β-cell dysfunction and metabolic syndrome [11].
Show more

10 Read more

Show all 8149 documents...